Get Premium to unlock powerful stock data

John G Ullman & Associates Inc Buys Merck Inc, Itron Inc, Ultra Clean Holdings Inc, Sells Johnson & Johnson, GlaxoSmithKline PLC, Albemarle Corp

Author's Avatar
insider
Nov 02, 2021
Article's Main Image
Corning, NY, based Investment company John G Ullman & Associates Inc (Current Portfolio) buys Merck Inc, Itron Inc, Ultra Clean Holdings Inc, Ortho Clinical Diagnostics Holdings PLC, II-VI Inc, sells Johnson & Johnson, GlaxoSmithKline PLC, Albemarle Corp, Xerox Holdings Corp, Alcon Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, John G Ullman & Associates Inc. As of 2021Q3, John G Ullman & Associates Inc owns 160 stocks with a total value of $735 million. These are the details of the buys and sells.

For the details of JOHN G ULLMAN & ASSOCIATES INC's stock buys and sells, go to https://www.gurufocus.com/guru/john+g+ullman+%26+associates+inc/current-portfolio/portfolio

These are the top 5 holdings of JOHN G ULLMAN & ASSOCIATES INC
  1. Emerson Electric Co (EMR) - 385,767 shares, 4.94% of the total portfolio. Shares reduced by 1.91%
  2. Pfizer Inc (PFE) - 643,450 shares, 3.76% of the total portfolio. Shares reduced by 1.55%
  3. OGE Energy Corp (OGE) - 783,244 shares, 3.51% of the total portfolio. Shares reduced by 0.24%
  4. Verizon Communications Inc (VZ) - 431,390 shares, 3.17% of the total portfolio. Shares added by 1.86%
  5. Corning Inc (GLW) - 635,820 shares, 3.16% of the total portfolio. Shares added by 4.20%
New Purchase: Ultra Clean Holdings Inc (UCTT)

John G Ullman & Associates Inc initiated holding in Ultra Clean Holdings Inc. The purchase prices were between $39.72 and $54.13, with an estimated average price of $47.21. The stock is now traded at around $53.450000. The impact to a portfolio due to this purchase was 0.4%. The holding were 68,404 shares as of 2021-09-30.

New Purchase: Ortho Clinical Diagnostics Holdings PLC (OCDX)

John G Ullman & Associates Inc initiated holding in Ortho Clinical Diagnostics Holdings PLC. The purchase prices were between $17.75 and $22.47, with an estimated average price of $20.16. The stock is now traded at around $19.175000. The impact to a portfolio due to this purchase was 0.31%. The holding were 122,519 shares as of 2021-09-30.

New Purchase: Bloom Energy Corp (BE)

John G Ullman & Associates Inc initiated holding in Bloom Energy Corp. The purchase prices were between $18.54 and $26.62, with an estimated average price of $21.25. The stock is now traded at around $32.275000. The impact to a portfolio due to this purchase was 0.25%. The holding were 96,700 shares as of 2021-09-30.

New Purchase: State Street Corporation (STT)

John G Ullman & Associates Inc initiated holding in State Street Corporation. The purchase prices were between $79.59 and $94.28, with an estimated average price of $87.03. The stock is now traded at around $99.315000. The impact to a portfolio due to this purchase was 0.22%. The holding were 19,000 shares as of 2021-09-30.

New Purchase: ACV Auctions Inc (ACVA)

John G Ullman & Associates Inc initiated holding in ACV Auctions Inc. The purchase prices were between $17.89 and $25.18, with an estimated average price of $21.27. The stock is now traded at around $19.365000. The impact to a portfolio due to this purchase was 0.17%. The holding were 69,784 shares as of 2021-09-30.

New Purchase: Eagle Bancorp Montana Inc (EBMT)

John G Ullman & Associates Inc initiated holding in Eagle Bancorp Montana Inc. The purchase prices were between $21.62 and $23.13, with an estimated average price of $22.25. The stock is now traded at around $22.600000. The impact to a portfolio due to this purchase was 0.17%. The holding were 55,135 shares as of 2021-09-30.

Added: Merck & Co Inc (MRK)

John G Ullman & Associates Inc added to a holding in Merck & Co Inc by 60.56%. The purchase prices were between $71.68 and $78.83, with an estimated average price of $76.11. The stock is now traded at around $89.780000. The impact to a portfolio due to this purchase was 0.49%. The holding were 127,523 shares as of 2021-09-30.

Added: Itron Inc (ITRI)

John G Ullman & Associates Inc added to a holding in Itron Inc by 615.17%. The purchase prices were between $71.84 and $100.87, with an estimated average price of $85.82. The stock is now traded at around $80.270000. The impact to a portfolio due to this purchase was 0.46%. The holding were 51,850 shares as of 2021-09-30.

Added: II-VI Inc (IIVI)

John G Ullman & Associates Inc added to a holding in II-VI Inc by 215.55%. The purchase prices were between $59.29 and $74.08, with an estimated average price of $65.35. The stock is now traded at around $63.480000. The impact to a portfolio due to this purchase was 0.29%. The holding were 51,750 shares as of 2021-09-30.

Added: Vanguard FTSE Emerging Markets ETF (VWO)

John G Ullman & Associates Inc added to a holding in Vanguard FTSE Emerging Markets ETF by 178.69%. The purchase prices were between $48.9 and $53.52, with an estimated average price of $51.26. The stock is now traded at around $50.600000. The impact to a portfolio due to this purchase was 0.24%. The holding were 54,119 shares as of 2021-09-30.

Added: BTC iShares MSCI Emerging Markets Min Vol Factor E (EEMV)

John G Ullman & Associates Inc added to a holding in BTC iShares MSCI Emerging Markets Min Vol Factor E by 163.98%. The purchase prices were between $61.06 and $64.43, with an estimated average price of $62.91. The stock is now traded at around $63.115000. The impact to a portfolio due to this purchase was 0.22%. The holding were 42,500 shares as of 2021-09-30.

Added: McAfee Corp (MCFE)

John G Ullman & Associates Inc added to a holding in McAfee Corp by 120.05%. The purchase prices were between $20.9 and $31.26, with an estimated average price of $25.91. The stock is now traded at around $21.325000. The impact to a portfolio due to this purchase was 0.16%. The holding were 95,500 shares as of 2021-09-30.

Sold Out: Albemarle Corp (ALB)

John G Ullman & Associates Inc sold out a holding in Albemarle Corp. The sale prices were between $167.91 and $244.03, with an estimated average price of $213.35.

Sold Out: Alcon Inc (ALC)

John G Ullman & Associates Inc sold out a holding in Alcon Inc. The sale prices were between $68.18 and $87.25, with an estimated average price of $76.98.

Sold Out: China Yuchai International Ltd (CYD)

John G Ullman & Associates Inc sold out a holding in China Yuchai International Ltd. The sale prices were between $12.63 and $16.31, with an estimated average price of $14.55.

Sold Out: (USCR)

John G Ullman & Associates Inc sold out a holding in . The sale prices were between $71.96 and $74.41, with an estimated average price of $73.36.

Sold Out: SPDR S&P China ETF (GXC)

John G Ullman & Associates Inc sold out a holding in SPDR S&P China ETF. The sale prices were between $108.07 and $131.38, with an estimated average price of $117.11.

Sold Out: Quest Diagnostics Inc (DGX)

John G Ullman & Associates Inc sold out a holding in Quest Diagnostics Inc. The sale prices were between $132.95 and $158, with an estimated average price of $146.26.



Here is the complete portfolio of JOHN G ULLMAN & ASSOCIATES INC. Also check out:

1. JOHN G ULLMAN & ASSOCIATES INC's Undervalued Stocks
2. JOHN G ULLMAN & ASSOCIATES INC's Top Growth Companies, and
3. JOHN G ULLMAN & ASSOCIATES INC's High Yield stocks
4. Stocks that JOHN G ULLMAN & ASSOCIATES INC keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus